Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
Genotyping Begins On NIDA's Biorepository Of Over 50,000 Samples - Affymetrix, BioRealm, And RUCDR Infinite Biologics Team Up To Help Study The Genetics Of Addiction

Genotyping Begins On NIDA's Biorepository Of Over 50,000 Samples - Affymetrix, BioRealm, And RUCDR Infinite Biologics Team Up To Help Study The Genetics Of Addiction

Affymetrix, Inc. (NASDAQ:AFFX), BioRealm, LLC, and RUCDR Infinite Biologics today announced a broad strategic alliance.

Affymetrix To Report Second Quarter 2015 Operating Results On Wednesday July 29, 2015

Affymetrix To Report Second Quarter 2015 Operating Results On Wednesday July 29, 2015

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will report operating results for the second quarter of 2015 after market close on Wednesday July 29, 2015.

Affymetrix Becomes Oversold (AFFX)

Affymetrix Becomes Oversold (AFFX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of February 2016 Options Trading For Affymetrix (AFFX)

First Week of February 2016 Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options begin trading this week, for the February 2016 expiration.

Affymetrix Becomes Oversold (AFFX)

Affymetrix Becomes Oversold (AFFX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Affymetrix Appoints Riccardo Pigliucci To Board Of Directors

Affymetrix Appoints Riccardo Pigliucci To Board Of Directors

Affymetrix (NASDAQ: AFFX) today announced that Riccardo Pigliucci has been appointed to the company's board of directors effective May 13, 2015.

Affymetrix Acquires Assets Of Eureka Genomics Corporation To Provide High Throughput And Economical Crop And Animal Genotyping

Affymetrix Acquires Assets Of Eureka Genomics Corporation To Provide High Throughput And Economical Crop And Animal Genotyping

Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics® Corporation for $15 million in an all cash transaction.

Affymetrix Reports First Quarter 2015 Operating Results

Affymetrix Reports First Quarter 2015 Operating Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the first quarter of 2015.

Affymetrix And EverGene Ltd., A Subsidiary Of MTI Ltd., Collaborate In Genetic Research And Personal Genomics Services In Japan

Affymetrix And EverGene Ltd., A Subsidiary Of MTI Ltd., Collaborate In Genetic Research And Personal Genomics Services In Japan

Affymetrix (NASDAQ:AFFX) and MTI Ltd. (TSE:9438), through its wholly-owned subsidiary, EverGene Ltd.

Affymetrix To Report First Quarter 2015 Operating Results On Wednesday April 29, 2015

Affymetrix To Report First Quarter 2015 Operating Results On Wednesday April 29, 2015

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the first quarter of 2015 after market close on Wednesday April 29, 2015.

Affymetrix (AFFX) Is Today's Dead Cat Bounce Stock

Affymetrix (AFFX) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Affymetrix (AFFX) as a "dead cat bounce" (down big yesterday but up big today) candidate

First Week Of AFFX November 20th Options Trading

First Week Of AFFX November 20th Options Trading

Investors in Affymetrix, Inc. saw new options begin trading this week, for the November 20th expiration.

First Week of AFFX April 17th Options Trading

First Week of AFFX April 17th Options Trading

Investors in Affymetrix, Inc. saw new options begin trading this week, for the April 17th expiration.

'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140

'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140

Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.

Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness

Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness

Lots of investors are worried about Europe, Cramer says, but you don't have to be.

Affymetrix To Webcast Presentation At The 2015 Leerink Global Healthcare Conference

Affymetrix To Webcast Presentation At The 2015 Leerink Global Healthcare Conference

Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company's presentation at the Leerink Global Healthcare Conference in New York City on Wednesday February 11, 2015.

Affymetrix Reports Fourth Quarter And Fiscal Year 2014 Results

Affymetrix Reports Fourth Quarter And Fiscal Year 2014 Results

Affymetrix, Inc. (NASDAQ:AFFX) today reported its operating results for the three and twelve months ended December 31, 2014.

Affymetrix Chairman And Founder To Retire From Board Of Directors

Affymetrix Chairman And Founder To Retire From Board Of Directors

Affymetrix (NASDAQ:AFFX) today announced that Founder and Chairman, Stephen Fodor, Ph.

Interesting AFFX Put And Call Options For March 20th

Interesting AFFX Put And Call Options For March 20th

Investors in Affymetrix, Inc. saw new options become available this week, for the March 20th expiration.

Affymetrix To Report Fourth Quarter And Fiscal Year 2014 Operating Results On Wednesday February 4, 2015

Affymetrix To Report Fourth Quarter And Fiscal Year 2014 Operating Results On Wednesday February 4, 2015

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will report operating results for the fourth quarter and fiscal year 2014 after market close on Wednesday February 4, 2015.

Affymetrix (AFFX) Stock Falls Today on Analyst Downgrade

Affymetrix (AFFX) Stock Falls Today on Analyst Downgrade

Shares of Affymetrix (AFFX) were down in late morning trading Wednesday after Robert W. Baird downgraded the stock to 'neutral' from 'outperform' and maintained its $11 price target.

Don't Miss Today's Strong And Under The Radar Stock: Affymetrix (AFFX)

Don't Miss Today's Strong And Under The Radar Stock: Affymetrix (AFFX)

Trade-Ideas LLC identified Affymetrix (AFFX) as a strong and under the radar candidate

Affymetrix (AFFX) Is Strong On High Volume Today

Affymetrix (AFFX) Is Strong On High Volume Today

Trade-Ideas LLC identified Affymetrix (AFFX) as a strong on high relative volume candidate

— Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue Of Approximately $93 Million And The Appointment Of Merilee Raines To The Board Of Directors —

— Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue Of Approximately $93 Million And The Appointment Of Merilee Raines To The Board Of Directors —

Affymetrix, Inc., (NASDAQ:AFFX) today announced that based on preliminary, unaudited financial data, the Company expects total revenue for the fourth quarter of 2014 to be approximately $93 million.

Affymetrix Expands Portfolio Of Axiom Genotyping Arrays For Agrigenomics With New Offerings For Porcine And Equine Studies

Affymetrix Expands Portfolio Of Axiom Genotyping Arrays For Agrigenomics With New Offerings For Porcine And Equine Studies

Affymetrix, Inc. (NASDAQ: AFFX) will be highlighting several new genotyping arrays at the 2015 Plant and Animal Genome Conference (PAGXXIII) for applications in breeding and routine analysis.

No Big Surprises Expected in Jobs Report

But an outlier would suggest a selloff on weakness and rally on strength.

Today's Strong And Under The Radar Stock: Affymetrix (AFFX)

Today's Strong And Under The Radar Stock: Affymetrix (AFFX)

Trade-Ideas LLC identified Affymetrix (AFFX) as a strong and under the radar candidate

First Week of AFFX August 2015 Options Trading

First Week of AFFX August 2015 Options Trading

Investors in Affymetrix, Inc. saw new options begin trading this week, for the August 2015 expiration.

EBioscience, An Affymetrix Business, Launches The First Assay To Detect RNA And Protein Simultaneously In Millions Of Single Cells

EBioscience, An Affymetrix Business, Launches The First Assay To Detect RNA And Protein Simultaneously In Millions Of Single Cells

eBioscience, an Affymetrix (Nasdaq:AFFX) business, announces the availability of PrimeFlow™ RNA Assay, the first and only flow cytometry assay capable of simultaneous detection of RNA and protein within...

The Binding Site And EBioscience, An Affymetrix Business, Partner In Clinical Flow Cytometry Reagent Agreement

The Binding Site And EBioscience, An Affymetrix Business, Partner In Clinical Flow Cytometry Reagent Agreement

Affymetrix (NASDAQ:AFFX) announces that eBioscience, an Affymetrix business, and Binding Site Group Ltd.